Philip B. Simon, C.P.A. is the current Chairman of the Company’s Board of Directors. Mr. Simon is a partner of Howson & Simon LLP and the president of Lawrence Investments, LLC, one of Quark’s major investors. Mr. Simon serves on the boards of directors of several private companies affiliated with Lawrence Investments. Mr. Simon joined Lawrence Investments in 1997. Mr. Simon has worked for 25 years as a partner at Howson & Simon. Mr. Simon holds an A.B. from Yale University and a J.D. from Stanford Law School. He is a member of the California Society of Certified Public Accountants.

Daniel Zurr, Ph.D. is the Company’s President, Chief Executive Officer and a current member of the Board of Directors. Dr. Zurr founded Quark in 1993. Prior to joining Quark, Dr. Zurr served as Vice President for Corporate Business Development for Israel Chemicals, Ltd. From 1980 to 1983, Dr. Zurr served as the Director of Licensing at G.D. Searle, a specialty pharmaceutical company. Dr. Zurr was the Chief Executive Officer of Plantex-Ikapharm, a pharmaceutical company, from 1972 to 1980. Dr. Zurr obtained his M.Sc. at the Hebrew University of Jerusalem and his Ph.D. from Imperial College, University of London.

Yoshitaka Kitao is the Chief Executive Officer and Representative Director of SBI Holdings, Inc., SBI Investment Co., Ltd., SBI Capital Co., Ltd. and SBI Card Co., Ltd. He is the Chief Executive Officer and Director of SBI VeriTrans Co., Ltd. and Morningstar Japan K.K. He is the Chairman and Director of SBI Mortgage Co., Ltd., Gomez Consulting Co., Ltd. and SBI Securities Co., Ltd. He is the Representative Director of Wall Street Journal Japan K.K. and Director of SBI Benefit Systems Co., Ltd. He was Executive Vice President and Chief Financial Officer of SOFTBANK Corp. from 1995 to 2000 and a Director of SOFTBANK Corp. from 2000 to 2005. He was the Chief Executive Officer and Representative Director of SOFTBANK Finance Corporation from 1999 to 2005. Previously, Mr. Kitao was also the Director of Nomura Wasserstein Perella Co., Ltd. from 1991 to 1992, Managing Director of Wasserstein Perella & Co. International, Ltd. from 1989 to 1992 and was the General Manager for the Nomura Securities Co., Ltd. Corporate Finance and Services Dept. III from 1992 to 1995. Mr. Kitao obtained degrees in Economics from Keio University and Cambridge University.

Robert Takeuchi is currently a director of SBI Investment Co., Ltd. a private equity investment company. From 1996 to 2004 he was President of SOFTBANK Finance, America Corporation and from 1988 to 1996 he was a Director of CS First Boston. Mr. Takeuchi obtained a B.A. in Economics form the University of California, Los Angeles.

Toru Mio is Chief Executive of Mio & Company Inc., a management consulting company based in Tokyo, Japan. From 1988 to 2005 Mr. Mio held various management positions at Nikko Citigroup Limited, including head of the Mergers and Acquisitions Group and co-head of the Consumer & Healthcare Group, where he engaged in a wide range of investment banking activities. From 2005 to 2010, he was a founding partner and investment committee member of Asuka DBJ Partners Co., Ltd. Mr. Mio also presently serves as Vice Chairman of Monex Hambrecht & Co. Japan, Inc., Director of So-net Entertainment Corporation, and Advisor of Japan Asia Investment Co., Ltd.. He holds a M.A. in International Relations from the Graduate School of Arts and Sciences, University of Tokyo, and a B.A. in Latin American studies from the University of Tokyo.

Philip M. Hahn served as Vice President and Assistant General Counsel at Pfizer, Inc. from 1978 to 2008. Mr. Hahn has extensive experience in structuring, negotiating and drafting major licenses and collaborations with U.S. pharmaceutical and biotech companies, as well as European and Japanese companies and broad experience in pharmaceutical and medical device businesses, including research, development, manufacturing and commercialization of products in the U.S. and ex-US markets. Mr. Hahn is also knowledgeable in the areas of commercial, patent, anti-trust, bankruptcy, food and drug, and licensing law. Mr. Hahn is a member of the Bar of the City of New York (Member, Committee on Medicine and Law, Committee on Professional Responsibility, Patent Law Committee); New York State Bar Association; Lecturer, American Conference Institute and CLE programs of Association of Bar of City of New York; Member of New York Regional Board of Anti-Defamation League. Mr. Hahn holds an A.B. magna cum laude from Brown University, an L.L.B. from Yale Law School.